CERE Overview
Upcoming Projects (CERE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CERE)
-
Examining the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease
Tickers: ABBV, CERE
Executed On: Feb 13, 2025 at 04:00 PM EST
Expired Projects (CERE)
-
Examining Cerevel Therapeutics' Tavapadon in Phase 3 Adjunctive Trial for Parkinson's Disease Management
Ticker: CERE
Execute By: May 31, 2024
Upcoming & Overdue Catalysts (CERE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (CERE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
